FDA Inspection 778051 — Brioschi Pharmaceuticals International LLC
The FDA completed an inspection of Brioschi Pharmaceuticals International LLC on Apr 25, 2012 in Fair Lawn, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 8 citations were issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 25, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Fair Lawn, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1133 | 21 CFR 211.25(a) | GMP Training Frequency |
| 1194 | 21 CFR 211.42(c) | Defined areas of adequate size for operations |
| 1883 | 21 CFR 211.165(a) | Testing and release for distribution |
| 2027 | 21 CFR 211.192 | Investigations of discrepancies, failures |
| 2619 | 21 CFR 211.198(b)(2) | Complaint Investigation/Follow-Up Findings |
| 3632 | 21 CFR 211.170(b) | Annual visual exams of drug products |
| 4369 | 21 CFR 211.188(b)(11) | Identification of persons involved, each significant step |
| 4377 | 21 CFR 211.188(b)(3) | Identification of each component or in-process material |